Cimpress PLC (CMPR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CMPR SEC filings page.
Cimpress PLC (CMPR) reported $3.7B in revenue for fiscal year 2026, up 9.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cimpress is growing revenue while converting profit to cash, but heavier reinvestment and a negative-equity balance sheet constrain flexibility.
In FY2026, operating cash flow of$283.7M was nearly three times net income of$95.9M , indicating earnings were supplemented by substantial noncash charges rather than relying only on reported profit. Free cash flow margin compressed from9.0% in FY2024 to4.9% in FY2026, showing that growth is requiring more reinvestment per dollar earned.
Gross margin fell from
The balance sheet carries negative equity of
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cimpress PLC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cimpress PLC has an operating margin of 6.7%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 56/100, indicating healthy but not exceptional operating efficiency. This is unchanged from the prior year.
Cimpress PLC's revenue grew 9.8% year-over-year to $3.7B, a solid pace of expansion. This earns a growth score of 56/100.
Cimpress PLC's current ratio of 0.73 is below the typical benchmark, resulting in a score of 9/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Cimpress PLC has a free cash flow margin of 4.9%, earning a moderate score of 50/100. The company generates positive cash flow after capital investments, but with room for improvement.
Cimpress PLC scores 2.55, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cimpress PLC passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Cimpress PLC generates $2.96 in operating cash flow ($283.7M OCF vs $95.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Cimpress PLC earns $2.37 in operating income for every $1 of interest expense ($251.0M vs $105.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Cimpress PLC generated $945.0M in revenue in Q4 2026. This represents an increase of 8.7% from the same quarter a year earlier. Against the prior quarter it is up 6.6%.
Cimpress PLC's EBITDA was $106.0M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 22.4%.
Cimpress PLC reported $25.1M in net income in Q4 2026. This represents an increase of 198.9% from the same quarter a year earlier. Against the prior quarter it is up 81.0%.
Cimpress PLC earned $0.98 per diluted share (EPS) in Q4 2026. This represents an increase of 200.0% from the same quarter a year earlier. Against the prior quarter it is up 78.2%.
Cash & Balance Sheet
Cimpress PLC generated $84.8M in free cash flow in Q4 2026, representing cash available after capex. This represents a decrease of 2.1% from the same quarter a year earlier. Against the prior quarter it is up 314.6%.
Cimpress PLC held $248.9M in cash against $1.6B in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Margins & Returns
Cimpress PLC's gross margin was 45.5% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.
Cimpress PLC's operating margin was 6.9% in Q4 2026, reflecting core business profitability. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.
Cimpress PLC's net profit margin was 2.6% in Q4 2026, showing the share of revenue converted to profit. This is up 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.
Not reported for Q4 2026.
Capital Allocation
Cimpress PLC repurchased no shares in Q4 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Cimpress PLC invested $25.7M in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 23.5% from the same quarter a year earlier. Against the prior quarter it is up 11.8%.
Not reported for Q4 2026.
CMPR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $945.0M+8.7% | $886.2M+12.3% | $1.0B+11.0% | $863.3M+7.2% | $869.5M+4.4% | $789.5M+1.1% | $939.2M+1.9% | $805.0M+6.3% |
| Cost of Revenue | $515.0M+12.8% | $477.0M+14.4% | $554.5M+13.3% | $460.5M+8.9% | $456.7M+6.7% | $417.0M+3.0% | $489.3M+5.6% | $422.7M+6.0% |
| Gross Profit | $430.0M+4.2% | $409.2M+9.8% | $487.7M+8.4% | $402.8M+5.4% | $412.8M+2.1% | $372.5M-0.9% | $449.9M-1.8% | $382.2M+6.6% |
| SG&A Expenses | $62.2M+5.2% | $58.9M+16.6% | $60.2M+5.7% | $54.0M+4.0% | $59.1M+8.8% | $50.5M-6.8% | $56.9M+16.7% | $51.9M+7.4% |
| Operating Income | $64.8M-1.0% | $49.2M+21.3% | $88.1M+8.8% | $49.0M+24.5% | $65.4M-1.3% | $40.5M+3.3% | $80.9M-24.8% | $39.3M+15.4% |
| EBITDA | $106.0M+4.4% | $86.6M+15.7% | $124.7M+7.4% | $85.6M+14.3% | $101.5M-0.5% | $74.8M-1.9% | $116.2M-20.9% | $74.9M+1.1% |
| Interest Expense | -$25.3M+8.6% | -$25.4M+5.9% | -$27.0M+7.4% | -$28.1M+10.7% | -$27.7M+7.4% | -$27.0M+10.5% | -$29.2M+4.7% | -$31.4M-7.6% |
| Income Tax | $12.9M-69.2% | $11.7M-3.6% | $13.3M-36.9% | $17.8M+98.3% | $41.8M+149.3% | $12.1M+14.5% | $21.2M+25.9% | $9.0M+10.7% |
| Net Income | $25.1M+198.9% | $13.8M+268.0% | $49.3M-19.2% | $7.6M+160.9% | -$25.3M-122.0% | -$8.2M-107.1% | $61.1M+5.1% | -$12.5M-375.6% |
| EPS (Basic) | $1.04+203.0% | $0.57+272.7% | $2.01-18.0% | $0.31+162.0% | -$1.01-122.9% | -$0.33-120.0% | $2.45+12.4% | -$0.50-394.1% |
| EPS (Diluted) | $0.98+200.0% | $0.55+266.7% | $1.95-17.4% | $0.30+160.0% | -$0.98-123.0% | -$0.33-120.0% | $2.36+10.3% | -$0.50-394.1% |
| Diluted Shares (Avg) | N/A | 25M+1.4% | 25M-2.3% | 25M-0.5% | N/A | 25M-5.3% | 26M-4.7% | 25M-7.1% |
Not reported in any period shown, so not listed: R&D Expenses.
CMPR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B+11.9% | $2.1B+9.4% | $2.1B+9.2% | $2.0B+4.4% | $2.0B+4.0% | $1.9B+5.3% | $1.9B-1.5% | $1.9B+4.1% |
| Current Assets | $564.5M+12.3% | $495.8M+11.7% | $561.2M+13.2% | $489.3M+14.4% | $502.6M+9.7% | $443.7M+0.3% | $495.6M-14.3% | $427.9M-3.6% |
| Cash & Equivalents | $248.9M+6.4% | $189.0M+3.3% | $258.0M+15.0% | $200.5M+31.1% | $234.0M+14.8% | $183.0M+18.6% | $224.4M-18.2% | $153.0M+22.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
| Inventory | $137.0M+21.4% | $123.8M+21.5% | $122.8M+18.8% | $119.5M+8.2% | $112.9M+16.3% | $101.9M+5.8% | $103.3M-1.3% | $110.5M-3.1% |
| Accounts Receivable | $73.6M+7.8% | $72.7M+9.9% | $70.6M+19.9% | $78.7M+6.7% | $68.3M+5.7% | $66.1M-6.9% | $58.9M-6.9% | $73.8M+7.1% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $850.8M+3.0% | $817.9M+3.2% | $826.7M+6.3% | $826.4M+2.7% | $826.2M+5.0% | $792.7M+1.7% | $777.6M-1.7% | $804.8M+4.2% |
| Total Liabilities | $2.6B+2.7% | $2.5B+3.9% | $2.6B+6.7% | $2.5B+3.6% | $2.5B+4.7% | $2.4B+0.3% | $2.5B-1.4% | $2.4B+0.7% |
| Current Liabilities | $775.6M+2.2% | $730.0M+7.4% | $826.1M+13.5% | $754.6M+12.6% | $758.7M+14.3% | $679.7M+6.9% | $727.8M+2.8% | $670.1M+4.8% |
| Non-Current Liabilities | $1.8B+2.9% | $1.8B+2.5% | $1.8B+3.9% | $1.8B+0.2% | $1.8B+1.0% | $1.7B-2.1% | $1.7B-3.0% | $1.8B-0.7% |
| Long-Term Debt | $1.6B+1.3% | $1.6B-0.2% | $1.6B-0.1% | $1.6B-0.7% | $1.6B-1.0% | $1.6B-0.8% | $1.6B-1.4% | $1.6B-0.6% |
| Total Equity | -$494.0M+15.3% | -$524.1M+6.0% | -$530.7M+4.3% | -$571.3M0.0% | -$583.5M-6.1% | -$557.5M+12.3% | -$554.5M-0.3% | -$571.0M+7.0% |
| Retained Earnings | $279.4M+24.1% | $256.4M-3.7% | $260.9M-6.0% | $230.7M-8.1% | $225.1M-17.5% | $266.2M+29.0% | $277.6M-6.7% | $250.9M+4.7% |
CMPR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $110.5M+2.8% | -$16.5M-270.4% | $164.7M-6.7% | $25.1M+471.6% | $107.5M-14.1% | $9.7M+15.0% | $176.5M+0.9% | $4.4M-89.6% |
| Depreciation & Amortization | $41.2M+14.2% | $37.4M+9.1% | $36.6M+4.0% | $36.6M+3.0% | $36.1M+1.2% | $34.3M-7.5% | $35.2M-9.9% | $35.5M-11.0% |
| Stock-Based Compensation | N/A | N/A | N/A | $14.8M-5.4% | N/A | N/A | N/A | $15.6M+25.5% |
| Capital Expenditures | $25.7M+23.5% | $23.0M-7.2% | $25.2M-4.7% | $26.4M+55.0% | $20.8M+98.2% | $24.8M+136.8% | $26.4M+131.9% | $17.0M-24.7% |
| Free Cash Flow | $84.8M-2.1% | -$39.5M-161.8% | $139.5M-7.1% | -$1.3M+89.7% | $86.7M-24.4% | -$15.1M-639.0% | $150.1M-8.2% | -$12.6M-164.1% |
| Investing Cash Flow | -$62.7M-71.4% | -$39.3M+4.4% | -$50.7M-35.1% | -$42.8M-67.9% | -$36.6M-269.4% | -$41.1M-187.2% | -$37.6M-91.9% | -$25.5M-135.6% |
| Financing Cash Flow | $12.5M+143.9% | -$8.9M+33.1% | -$57.0M+2.9% | -$14.7M+58.6% | -$28.5M+56.2% | -$13.3M+87.9% | -$58.7M-385.2% | -$35.4M-1.0% |
| Share Buybacks | $0-100.0% | $21.9M+454.6% | $25.5M-39.9% | $2.7M-74.3% | $20.8M-63.0% | $3.9M-96.1% | $42.4M | $10.6M |
Not reported in any period shown, so not listed: Dividends Paid.
CMPR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.5%-2.0pp | 46.2%-1.0pp | 46.8%-1.1pp | 46.7%-0.8pp | 47.5%-1.1pp | 47.2%-1.0pp | 47.9%-1.8pp | 47.5%+0.1pp |
| Operating Margin | 6.9%-0.7pp | 5.5%+0.4pp | 8.5%-0.2pp | 5.7%+0.8pp | 7.5%-0.4pp | 5.1%+0.1pp | 8.6%-3.1pp | 4.9%+0.4pp |
| Net Margin | 2.6%+5.6pp | 1.6%+2.6pp | 4.7%-1.8pp | 0.9%+2.4pp | -2.9%-16.7pp | -1.0%-0.5pp | 6.5%+0.2pp | -1.6%-2.2pp |
| Return on Assets | 1.1%+2.4pp | 0.7%+1.1pp | 2.4%-0.8pp | 0.4%+1.1pp | -1.3%-7.4pp | -0.4%-0.2pp | 3.2%+0.2pp | -0.7%-0.9pp |
| Current Ratio | 0.73+0.1x | 0.680.0x | 0.680.0x | 0.650.0x | 0.660.0x | 0.650.0x | 0.68-0.1x | 0.64-0.1x |
| Asset Turnover | 0.430.0x | 0.430.0x | 0.500.0x | 0.440.0x | 0.440.0x | 0.420.0x | 0.490.0x | 0.430.0x |
| FCF Margin | 9.0%-1.0pp | -4.5%-2.6pp | 13.4%-2.6pp | -0.1%+1.4pp | 10.0%-3.8pp | -1.9%-1.7pp | 16.0%-1.8pp | -1.6%-4.2pp |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.
Note: Shareholder equity is negative (-$494.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.73), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cimpress PLC CMPR | FY2026 | $3.7B | $95.9M | 2.6% | $1.8B | 44/100 |
| BrightView Holdings, Inc. BV | FY2025 | $2.7B | $56.0M | 2.1% | $998.2M | 39/100 |
| LegalZoom.com, Inc. LZ | FY2025 | $756.0M | $15.4M | 2.0% | $1.0B | 46/100 |
| Target Hospitality Corp. TH | FY2025 | $320.6M | -$37.1M | -11.6% | $1.8B | 38/100 |
| Transcat Inc TRNS | FY2026 | $331.9M | $5.4M | 1.6% | $805.1M | 56/100 |
| EASTMAN KODAK COMPANY KODK | FY2025 | $1.1B | -$128.0M | -12.0% | $895.8M | 59/100 |
Where Cimpress PLC Ranks
Frequently Asked Questions
What is Cimpress PLC's annual revenue?
Cimpress PLC (CMPR) reported $3.7B in total revenue for fiscal year 2026. This represents a 9.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cimpress PLC's revenue growing?
Cimpress PLC (CMPR) revenue grew by 9.8% year-over-year, from $3.4B to $3.7B in fiscal year 2026.
Is Cimpress PLC profitable?
Yes, Cimpress PLC (CMPR) reported a net income of $95.9M in fiscal year 2026, with a net profit margin of 2.6%.
What is Cimpress PLC's EBITDA?
Cimpress PLC (CMPR) had EBITDA of $402.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Cimpress PLC have?
As of fiscal year 2026, Cimpress PLC (CMPR) had $248.9M in cash and equivalents against $1.6B in long-term debt.
What is Cimpress PLC's gross margin?
Cimpress PLC (CMPR) had a gross margin of 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cimpress PLC's operating margin?
Cimpress PLC (CMPR) had an operating margin of 6.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Cimpress PLC's net profit margin?
Cimpress PLC (CMPR) had a net profit margin of 2.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Cimpress PLC's free cash flow?
Cimpress PLC (CMPR) generated $183.5M in free cash flow during fiscal year 2026. This represents a -12.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cimpress PLC's operating cash flow?
Cimpress PLC (CMPR) generated $283.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Cimpress PLC's total assets?
Cimpress PLC (CMPR) had $2.2B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Cimpress PLC's capital expenditures?
Cimpress PLC (CMPR) invested $100.2M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Cimpress PLC spend on research and development?
Cimpress PLC (CMPR) invested $68.6M in research and development during fiscal year 2026.
What is Cimpress PLC's current ratio?
Cimpress PLC (CMPR) had a current ratio of 0.73 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.
What is Cimpress PLC's return on assets (ROA)?
Cimpress PLC (CMPR) had a return on assets of 4.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Cimpress PLC's P/E ratio?
Cimpress PLC (CMPR) trades at 19.0x earnings, its market capitalization divided by net income of $95.9M net income, FY2026. The market capitalization is $1.8B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cimpress PLC's price-to-sales ratio?
Cimpress PLC (CMPR) trades at 0.5x sales, its market capitalization divided by revenue of $3.7B revenue, FY2026. The market capitalization is $1.8B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is Cimpress PLC's debt-to-equity ratio negative or not reported?
Cimpress PLC (CMPR) has negative shareholder equity of -$494.0M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Cimpress PLC's Altman Z-Score?
Cimpress PLC (CMPR) has an Altman Z-Score of 2.55, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cimpress PLC's Piotroski F-Score?
Cimpress PLC (CMPR) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cimpress PLC's earnings high quality?
Cimpress PLC (CMPR) has an earnings quality ratio of 2.96x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cimpress PLC cover its interest payments?
Cimpress PLC (CMPR) has an interest coverage ratio of 2.37x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cimpress PLC?
Cimpress PLC (CMPR) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.